
BrainChild Biorevenue
Seattle, WashingtonFounded 2023CEO Steven Brugger
BrainChild Bio is a kids-first, clinical-stage biotechnology company focusing on harnessing CAR T-cell technology for tumors in the central nervous system, particularly pediatric brain tumors.
BrainChild Bio revenue
BrainChild Bio has not published its revenue. Growjo puts it at about $7.8M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $7.8MEST | Growjo estimate |
BrainChild Bio CEO & employees
Steven Brugger is CEO of BrainChild Bio. BrainChild Bio has 40 employees (September 2025, LinkedIn).
BrainChild Bio FAQ
What is BrainChild Bio's revenue?
Growjo estimates BrainChild Bio's revenue at about $7.8M a year (September 2025). The company hasn't published its own figure.
How many employees does BrainChild Bio have?
BrainChild Bio has 40 employees as of September 2025, according to LinkedIn.
Who is the CEO of BrainChild Bio?
Steven Brugger is the CEO of BrainChild Bio.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun BrainChild Bio? Join the podcast